Consensus ranking approach to understanding the underlying mechanism with QSAR

Journal of Chemical Information and Modeling

Volumn 50, Issue 11, 2010, Pages 1941-1948

  Shao, Li ^a   Wu, Leihong ^a   Fan, Xiaohui ^a   Cheng, Yiyu ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PREDICTIVE ANALYTICS;

MECHANISTIC ANALYSIS; MODEL CONSTRUCTION; MODEL DEVELOPMENT; MODEL PERFORMANCE; PREDICTIVE CAPABILITIES; PREDICTIVE MODELING; QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP; SPECIFIC PROPERTIES;

COMPUTATIONAL CHEMISTRY;

ARTICLE; MULTIVARIATE ANALYSIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REPRODUCIBILITY; STATISTICAL MODEL;

LINEAR MODELS; MULTIVARIATE ANALYSIS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REPRODUCIBILITY OF RESULTS;

EID: 78649494564     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci100305g     Document Type: Article

References (32)

1. Katritzky, A. R.; Karelson, M.; Lobanov, V. S. QSPR as a means of predicting and understanding chemical and physical properties in terms of structure Pure Appl. Chem. 1997, 69, 245-248
2. Katritzky, A. R.; Lobanov, V. S.; Karelson, M. QSPR-The correlation and quantitative prediction of chemical and physical properties from structure Chem. Soc. Rev. 1995, 24, 279-287
3. Fjodorova, N.; Novich, M.; Vrachko, M.; Smirnov, V.; Kharchevnikova, N.; Zholdakova, Z.; Novikov, S.; Skvortsova, N.; Filimonov, D.; Poroikov, V.; Benfenati, E. Directions in QSAR modeling for regulatory uses in OECD member countries, EU and in Russia J. Environ. Sci. Health, Part C: Environ. Carcinog. Ecotoxicol. Rev. 2008, 26, 201-236 (Pubitemid 352000640)
4. Salum, L. B.; Andricopulo, A. D. Fragment-based QSAR strategies in drug design Expert Opin. Drug Discovery 2010, 5, 405-412
5. Tsygankova, I. G. Variable selection in QSAR models for drug design Curr. Comput.-Aided Drug Des. 2008, 4, 132-142
6. Fatemi, M. H.; Malekzadeh, H. Prediction of Log(IGC(50))(-1) for Benzene Derivatives to Ciliate Tetrahymena pyriformis from Their Molecular Descriptors Bull. Chem. Soc. Jpn. 2010, 83, 233-245
7. Garkani-Nejad, Z.; Ahmadi-Roudi, B. Modeling the antileishmanial activity screening of 5-nitro-2-heterocyclic benzylidene hydrazides using different chemometrics methods Eur. J. Med. Chem. 2010, 45, 719-726
8. Perez-Garrido, A.; Helguera, A. M.; Rodriguez, F. G.; Cordeiro, M. QSAR models to predict mutagenicity of acrylates, methacrylates and alpha, beta-unsaturated carbonyl compounds Dent. Mater. 2010, 26, 397-415
9. Duchowicz, P. R.; Vitale, M. G.; Castro, E. A.; Autino, J. C.; Romanelli, G. P.; Bennardi, D. O. QSAR modeling of the interaction of flavonoids with GABA(A) receptor Eur. J. Med. Chem. 2008, 43, 1593-1602
10. Li, J. Z.; Du, J.; Xi, L. L.; Liu, H. X.; Yao, X. J.; Liu, M. C. Validated quantitative structure-activity relationship analysis of a series of 2-aminothiazole based p56(Lck) inhibitors Anal. Chim. Acta 2009, 631, 29-39
11. Mercader, A. G.; Duchowicz, P. R.; Fernandez, F. M.; Castro, E. A.; Bennardi, D. O.; Autino, J. C.; Romanelli, G. P. QSAR prediction of inhibition of aldose reductase for flavonoids Bioorg. Med. Chem. 2008, 16, 7470-7476
12. Sharma, S.; Prabhakar, Y. S.; Singh, P.; Sharma, B. K. QSAR study about ATP-sensitive potassium channel activation of cromakalim analogues using CP-MLR approach Eur. J. Med. Chem. 2008, 43, 2354-2360
13. Mercader, A. G.; Duchowicz, P. R.; Fernandez, F. M.; Castro, E. A. Modified and enhanced replacement method for the selection of molecular descriptors in QSAR and QSPR theories Chemom. Intell. Lab. Syst. 2008, 92, 138-144
14. Sun, M.; Zheng, Y. G.; Wei, H. T.; Chen, J. Q.; Cai, J.; Ji, M. Enhanced Replacement Method-based Quantitative Structure-Activity Relationship Modeling and Support Vector Machine Classification of 4-Anilino-3-quinolinecarbonitriles as Src Kinase Inhibitors QSAR Comb. Sci. 2009, 28, 312-324
15. Sun, M.; Chen, J. Q.; Wei, H. T.; Yin, S. Q.; Yang, Y.; Ji, M. Quantitative Structure-Activity Relationship and Classification Analysis of Diaryl Ureas Against Vascular Endothelial Growth Factor Receptor-2 Kinase Using Linear and Non-Linear Models Chem. Biol. Drug Des. 2009, 73, 644-654
16. Zhu, H.; Tropsha, A.; Fourches, D.; Varnek, A.; Papa, E.; Gramatica, P.; Oberg, T.; Dao, P.; Cherkasov, A.; Tetko, I. V. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis J. Chem. Inf. Model. 2008, 48, 766-784
17. Mastalerz, H.; Chang, M.; Chen, P.; Fink, B. E.; Gavai, A.; Han, W. C.; Johnson, W.; Langley, D.; Lee, F. Y.; Leavitt, K.; Marathe, P.; Norris, D.; Oppenheimer, S.; Sleczka, B.; Tarrant, J.; Tokarski, J. S.; Vite, G. D.; Vyas, D. M.; Wong, H.; Wong, T. W.; Zhang, H. J.; Zhang, G. F. 5-((4-Aminopiperidin-1- yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases Bioorg. Med. Chem. Lett. 2007, 17, 4947-4954 (Pubitemid 47193182)
18. Mastalerz, H.; Chang, M.; Chen, P.; Dextraze, P.; Fink, B. E.; Gavai, A.; Goyal, B.; Han, W. C.; Johnson, W.; Langley, D.; Lee, F. Y.; Marathe, P.; Mathur, A.; Oppenheimer, S.; Ruediger, E.; Tarrant, J.; Tokarski, J. S.; Vite, G. D.; Vyas, D. M.; Wong, H.; Wong, T. W.; Zhang, H. J.; Zhang, G. F. New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases Bioorg. Med. Chem. Lett. 2007, 17, 2036-2042 (Pubitemid 46389580)
19. Ducray, R.; Ballard, P.; Barlaam, B. C.; Hickinson, M. D.; Kettle, J. G.; Ogilvie, D. J.; Trigwell, C. B. Novel 3-alkoxy-1H-pyrazolo[3,4-d]pyrimidines as EGFR and erbB2 receptor tyrosine kinase inhibitors Bioorg. Med. Chem. Lett. 2008, 18, 959-962 (Pubitemid 351187881)
20. Mastalerz, H.; Chang, M.; Gavai, A.; Johnson, W.; Langley, D.; Lee, F. Y.; Marathe, P.; Mathur, A.; Oppenheimer, S.; Tarrant, J.; Tokarski, J. S.; Vite, G. D.; Vyas, D. M.; Wong, H.; Wong, T. W.; Zhang, H. J.; Zhang, G. F. Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases Bioorg. Med. Chem. Lett. 2007, 17, 2828-2833 (Pubitemid 46656457)
21. Muraglia, E.; Kinzel, O.; Gardelli, C.; Crescenzi, B.; Donghi, M.; Ferrara, M.; Nizi, E.; Orvieto, F.; Pescatore, G.; Laufer, R.; Gonzalez-Paz, O.; Di Marco, A.; Fiore, F.; Monteagudo, E.; Fonsi, M.; Felock, P. J.; Rowley, M.; Summa, V. Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors J. Med. Chem. 2008, 51, 861-874
22. Pace, P.; Di Francesco, M. E.; Gardelli, C.; Harper, S.; Muraglia, E.; Nizi, E.; Orvieto, F.; Petrocchi, A.; Poma, M.; Rowley, M.; Scarpelli, R.; Laufer, R.; Paz, O. G.; Monteagudo, E.; Bonelli, F.; Hazuda, D.; Stillmock, K. A.; Summa, V. Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors J. Med. Chem. 2007, 50, 2225-2239
23. Gardelli, C.; Nizi, E.; Muraglia, E.; Crescenzi, B.; Ferrara, M.; Orvieto, F.; Pace, P.; Pescatore, G.; Poma, M.; Ferreira, M.; Scarpelli, R.; Homnick, C. F.; Ikemoto, N.; Alfieri, A.; Verdirame, M.; Bonelli, F.; Paz, O. G.; Taliani, M.; Monteagudo, E.; Pesci, S.; Laufer, R.; Felock, P.; Stillmock, K. A.; Hazuda, D.; Rowley, M.; Summa, V. Discovery and synthesis of HIV integrase inhibitors: Development of potent and orally bioavailable N-methyl Pyrimidones J. Med. Chem. 2007, 50, 4953-4975
24. Stewart, J. J. P. Optimization of parameters for semiempirical methods. 1. method J. Comput. Chem. 1989, 10, 209-220
25. Dragon for Windows (Software for molecular Descriptor Calculation), version 5.4; Talete srl: Milano, Italy, 2006; http://www.talete.mi.it.
26. Wang, J. M.; Krudy, G.; Xie, X. Q.; Wu, C. D.; Holland, G. Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion J. Chem. Inf. Model. 2006, 46, 2674-2683
27. Tute, M. History and objectives of quantitative drug design in advances in drug research. In Comprehensive Medicinal Chemistry; Sammes, P.; Taylor, J., Eds.; Pergamon: Oxford, United Kingdom, 1990; Vol. 4, pp 1 - 32.
28. Hansch, C.; Sammes, P. G.; Taylor, J. B. Comprehensive Medicinal Chemistry: The Rational Design, Mechanistic Study & Therapeutic Application of Chemical Compounds,: Pergamon: New York, 1990; Vol. 6. pp 1 - 19.
29. Tan, P. K.; Downey, T. J.; Spitznagel, E. L.; Xu, P.; Fu, D.; Dimitrov, D. S.; Lempicki, R. A.; Raaka, B. M.; Cam, M. C. Evaluation of gene expression measurements from commercial microarray platforms Nucleic Acids Res. 2003, 31, 5676-5684
30. Ein-Dor, L.; Kela, I.; Getz, G.; Givol, D.; Domany, E. Outcome signature genes in breast cancer: is there a unique set Bioinformatics. 2005, 21, 171-178
31. Abeel, T.; Helleputte, T.; Van de Peer, Y.; Dupont, P.; Saeys, Y. Robust biomarker identification for cancer diagnosis with ensemble feature selection methods Bioinformatics. 2010, 26, 392-398
32. Shao, L.; Shen, P.; Qu, H. B.; Fan, X. H. Multiple ranking protocol for identifying reliable biomarkers in metabonomics. Anal. Chim. Acta; submitted.